Pereira Wogelsanger O, Paiva Aldair S, Queiroz José W, Toma Leny, Dietrich Carl P, Nader Helena B, Jerônimo Selma M B
Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo, Brazil.
Cancer Genet Cytogenet. 2005 Jul 1;160(1):55-60. doi: 10.1016/j.cancergencyto.2004.12.005.
Cytosolic sulfotransferases are enzymes that catalyze the conjugation of sulfate groups to a variety of xenobiotic and endogenous substrates. A mutation in the SULT1A1 gene has been associated with decreased sulfotransferase activity. We studied 125 cancer patients and 100 healthy controls from Brazil matched by age and gender. The objective of this study was to assess the impact of the SULT1A1 polymorphism on sulfotransferase activity in a population of cancer patients. Both heterozygous and homozygous individuals for the mutant allele had significantly decreased sulfotransferase enzymatic activity. This decrease was more significant in cancer patients. The frequency of the SULT1A1( *)2 allele was increased in the myeloma group (odds ratio=0.53). These data suggest a functional role for the SULT1A1 gene polymorphism in cancer.
胞质磺基转移酶是催化将硫酸基团与多种外源性和内源性底物结合的酶。SULT1A1基因的突变与磺基转移酶活性降低有关。我们研究了来自巴西的125名癌症患者和100名年龄和性别匹配的健康对照。本研究的目的是评估SULT1A1基因多态性对癌症患者群体中磺基转移酶活性的影响。突变等位基因的杂合子和纯合子个体的磺基转移酶酶活性均显著降低。这种降低在癌症患者中更为显著。骨髓瘤组中SULT1A1(*)2等位基因的频率增加(优势比=0.53)。这些数据表明SULT1A1基因多态性在癌症中具有功能作用。